• OPEN AN ACCOUNT
A+| A| A-|
Indian Indices
Sensex
75,415.35 231.99
( 0.31%)
Global Indices
Nasdaq
50,600.73 294.06
(0.58%)
Dow Jones
7,493.73 27.01
(0.36%)
Hang Seng
63,328.42 1,644.28
(2.67%)
Nikkei 225
10,474.02 30.55
(0.29%)
Forex
USD-INR
96.29 -0.42
(-0.43%)
EUR-INR
111.82 -0.44
(-0.39%)
GBP-INR
129.28 -0.40
(-0.31%)
JPY-INR
0.61 0.00
(-0.48%)

EQUITY - MARKET SCREENER

Refractory Shapes Ltd
Industry :  Refractories / Intermediates
BSE Code
ISIN Demat
Book Value()
92838
INE0TNX01015
20.6174312
NSE Symbol
P/E(TTM)
Mar.Cap( Cr.)
REFRACTORY
14.13
85.35
EPS(TTM)
Face Value()
Div & Yield %
2.77
10
0
 

stelis biopharma ltd
L&T Finance consolidated net profit rises 26.79% in the March 2026 quarter
Apr 25,2026
Net profit of L&T Finance rose 26.79% to Rs 806.63 crore in the quarter ended March 2026 as against Rs 636.17 crore during the previous quarter ended March 2025. Sales rose 18.60% to Rs 4771.03 crore in the quarter ended March 2026 as against Rs 4022.92 crore during the previous quarter ended March 2025.

For the full year,net profit rose 12.77% to Rs 2981.18 crore in the year ended March 2026 as against Rs 2643.66 crore during the previous year ended March 2025. Sales rose 12.49% to Rs 17913.67 crore in the year ended March 2026 as against Rs 15924.24 crore during the previous year ended March 2025.

ParticularsQuarter EndedYear Ended
Mar. 2026Mar. 2025% Var.Mar. 2026Mar. 2025% Var.
Sales4771.034022.92 19 17913.6715924.24 12
OPM %60.3960.70 -61.1460.35 -
PBDT1134.27846.50 34 4236.373630.16 17
PBT1073.92805.52 33 4026.683491.26 15
NP806.63636.17 27 2981.182643.66 13